A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro
Crossref DOI link: https://doi.org/10.1007/s00775-017-1498-4
Published Online: 2017-10-23
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Banerjee, Kaushik
Biswas, Manas Kumar
Choudhuri, Soumitra Kumar
License valid from 2017-10-23